XML 39 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Acquisition of Melinta (Tables)
 3 Months Ended
Mar. 31, 2026
Business Combination [Abstract]  
Schedule of Contingent Consideration Liability using Unobservable Level 3 Inputs The following table summarizes the change in fair value, as determined by Level 3 inputs, for the contingent consideration liability using unobservable Level 3 inputs for the three months ended March 31, 2026:
Contingent
Consideration
(Unaudited)
Balance as of December 31, 2025$102,116 
Payments against contingent consideration(742)
Change in fair value of contingent consideration liability4,199 
Balance as of March 31, 2026$105,573 
Schedule of Key Assumptions and Inputs in the Fair Value The following table summarizes key assumptions and inputs used in the fair value simulation as of the valuation dates:
Valuation DatesMarch 31,
2026		December 31,
2025
Risk-free rate over simulated period4.38%4.30%
Net sales of REZZAYO product volatility70.00%75.00%
Net sales REZZAYO product discount rate (continuous)13.15%13.15%
Net sales MINOCIN product discount rate (continuous)9.95%8.75%
Earnout payment discount rate (continuous)6.60%7.13%
REZZAYO Milestone payment discount rate5.86%6.25%
Schedule of Unaudited Pro Forma Financial Information
Three Months
Ended
March 31,
2026		Three Months Ended March 31, 2025
Total Revenue$127,427 $68,839 
Net Income$38,601 $12,917 
Net Income Per Common Share – Basic$0.48 $0.20 
Net Income Per Common Share – Diluted$0.43 $0.18